Tonix Pharmaceuticals releases more data from second positive Phase 3 clinical trial of TNX-102 SL

By Proactive Investors / January 26, 2024 / www.youtube.com / Article Link


Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to share additional safety and tolerability data ...

Recent News

Gold stocks gain on move back into metal

October 12, 2026 / www.canadianminingreport.com

Silver stocks gain over past year even as metal price weak

October 12, 2026 / www.canadianminingreport.com

Copper price estimates boosted by AOCE

October 05, 2026 / www.canadianminingreport.com

AOCE makes significant changes to metal estimates

October 05, 2026 / www.canadianminingreport.com

Big Gold still struggling overall in 2026

September 28, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok